VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,357,000 | +29.7% | 58,400 | -11.1% | 2.48% | +34.4% |
| Q1 2018 | $1,046,000 | -36.8% | 65,700 | -17.6% | 1.85% | +17.1% |
| Q4 2017 | $1,656,000 | +93.5% | 79,700 | +33.5% | 1.58% | +136.9% |
| Q3 2017 | $856,000 | -71.7% | 59,700 | -65.9% | 0.67% | -67.6% |
| Q2 2017 | $3,028,000 | +272.0% | 175,000 | +137.1% | 2.05% | +233.8% |
| Q1 2017 | $814,000 | -32.7% | 73,800 | -9.9% | 0.62% | -1.1% |
| Q4 2016 | $1,210,000 | -47.5% | 81,900 | -12.8% | 0.62% | -67.0% |
| Q3 2016 | $2,305,000 | +39.4% | 93,900 | +14.4% | 1.89% | +23.3% |
| Q2 2016 | $1,653,000 | -24.7% | 82,100 | +1.2% | 1.53% | +653.2% |
| Q1 2016 | $2,195,000 | – | 81,100 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |